Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults

• Published in: Psychoneuroendocrinology 2023-11, Vol.157, p.106369-106369, Article 106369
• Main Authors: Johnson-Ferguson, Lydia, Shanahan, Lilly, Bechtiger, Laura, Steinhoff, Annekatrin, Zimmermann, Josua, Baumgartner, Markus R., Binz, Tina M., Eisner, Manuel, Ribeaud, Denis, Quednow, Boris B.
• Format: Article
• Language: English
• Subjects: Cortisol; Cortisone; Drugs; Hair; Steroid hormones; Stress; Substance use; Testosterone
• ISSN: 0306-4530; 1873-3360
• DOI: 10.1016/j.psyneuen.2023.106369

Epidemiological studies increasingly use hair samples to assess people’s cumulative exposure to steroid hormones, but how the use of different psychoactive substances may affect steroid hormone levels in hair is, so far, largely unknown. The current study addresses this gap by establishing the substance exposure correlates of cortisol, cortisone, and testosterone in hair, while also accounting for a number of relevant covariates. Data came from a large urban community-sample of young adults with a high prevalence of substance use (N = 1002, mean age=20.6 years, 50.2% female), who provided 3 cm of hair samples. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) quantified cortisol, cortisone, and testosterone, as well as delta-9-tetrahydrocannabinol (THC), 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”), cocaine, several opioids, and their respective metabolites. Multiple linear regression models with covariates were used to predict steroid hormone levels from substance exposure in a four-step approach: In the full sample, low and high substance hair concentrations (median split) were first tested against no use for each substance individually (step 1) and for all substances together (step 2). Then, within the participants with any substance in hair only, the continuous hair concentration of each substance in pg/mg (step 3) and finally of all substances together, were regressed (step 4). Low, high, and continuous levels of THC in hair were robustly associated with higher levels of cortisol (sig. in step 1 low THC: β = 0.29, p = .021; high THC: β = 0.42, p = .001; step 2: low THC: β = 0.27, p = 0.036, and high THC: β = 0.40, p = .004, and step 4: β = 0.12, p = .041). Participants with high MDMA levels had higher levels of cortisone without adjusting for other substances (step 1: β = 0.34, p = .026), but this effect was not significant in the other models. While high THC levels were associated with lower levels of testosterone in step 2 (β = −0.35, p = .018), MDMA concentration was positively related to testosterone concentration with and without adjusting for other substances (step 3: β = 0.24, p = .041; step 4: β = 0.17, 95%, p = .015) in male participants. The use of psychoactive substances, especially of cannabis and ecstasy, should be considered in studies investigating steroid hormones in hair. •More THC in hair is associated with higher levels of cortisol in hair.•High levels of MDMA in hair is associated with higher levels of cortisone.•Mor